This Editorial makes the case that considering APOL1 risk variants in kidney transplantation will likely be an important clinical application that transforms current practice.
Authors: Barry I Freedman and Bruce A Julian
Reference: Kidney Int 87: 671-673; doi:10.1038/ki.2015.16
Additional Info
-
Language:
English -
Contains Audio:
No -
Content Type:
Articles -
Source:
KI -
Year:
2015 -
Members Only:
No